We are advancing a pipeline of cellular and genetic medicines designed to restore and strengthen heart muscle tissue. Our mission is to develop and commercialize first-in-class medicines for treatment of heart failure, the leading cause of death. The company brings together experts in heart regeneration, leading clinical institutions, and a broad technology platform to advance a pipeline of transformative medicines.